However, the causal relationship between taurine metabolic abnormalities and BLCA development requires validation in gene-edited animal models, and the specific regulatory pathways of genes such as FAAH and UCP2 in the metabolism-immunity axis need further clarification. This evidence concerns the gene UCP2 and bladder transitional cell carcinoma.